THE TAPE
BTSG · Home Health Care Services · $14.1B

BrightSpring Health Services, Inc. Common Stock

$71.37▲ +0.22%
Last close
Relative strength
95RS
of 99, against every stock▲ +8 on the month
Powering up
Unconfirmed
+26.8%
six months against the S&P 500
52-week range
−3.2%
from the high
$30.64$73.75
Setup
vcpforming
−3.2%
against the pivot at $73.75
No report date on the calendar.
Growth REALProof SHOWN
Quarter to Sep 30, revenue +26% on a year ago
11/16 O 71.43 H 72.08 L 70.70 Vol 3.1M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS95
vs pivot−3.23%
Tightening1.28×
Dry-up1.14×
Up/down vol0.20
From high3%
forming9 of 9checks
Powering up
Support and resistance
Support below
$63.91
-10.5% · tested 6× · last 6 sessions ago
Resistance above
$73.49
+3.0% · tested 4× · last 3 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 16.0 weeks and fell 26% from its ceiling at its deepest. The pivot is $73.75, and the stock closed 3.2% below it. Its relative strength rating is 95.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+20.9%
Three months against the S&P 500
+24.4%
Six months against the S&P 500
+26.8%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 10.0% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$15.3B
+26.4% year on year
Operating margin
3.4%
gross 12.5%
Net margin
2.7%
Free cash flow
$492.4M
3.5% of market cap
Price to sales
0.93×
Price to earnings
34.5×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 30
Key takeaway
Growth with the cash to show for it: the quarter confirms the thesis.
Revenue
$4.2B
+8.8% QoQ · +26.4% YoY
Gross margin
12.3%
-0.4 pts QoQ
Net income
$100.1M
Positive
Free cash flow
$182.2M
Cash generating

What the numbers say

  • Good: Revenue +26.4% year over year, +8.8% on the quarter
  • Gross margin 12.3%, -0.4 points on the quarter
  • Good: Profitable: net income $100M, operating margin 3.8%
  • Good: Cash generating: operating cash flow $204M, free cash flow $182M
  • Net debt $1.46B · cash $718M
Revenue by quarter
Free cash flow
Net income
shares +1.0% in a year · net debt $1.5B

The desk’s own read

Flagged as drifting up since the report

Final read
Growth: REAL · Economic proof: SHOWN
Key question: Does the next quarter repeat this one?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 3 of 46 tracked funds at the end of Q3 2026.

Last quarter: 3 bought new.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-11-10
range halved after a +17% thrust, at 69.15
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-06
above 20d & 50d on 1.6x volume at 65.86
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-11-06
-5.6%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-04
+5.4%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Reported resultsFiling · 2026-10-31
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-10-31
above 20d & 50d on 2.5x volume at 66.89
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-10-31
+11.1%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-10-31
+11.1% on earnings 2026-10-30
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
6
$1,727,608,632 total

Sold: Greenwell Scott A., KKR Group Partnership L.P., KKR Phoenix Aggregator L.P., ROUSSEAU JON B, Nalley Lisa A, Phipps Jennifer A.

Not counted above: 12 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-10-25 ROUSSEAU JON B · See Remarks, Directorwithheld for tax36,355$2,185,299
2026-09-14 Greenwell Scott A. · President, PharMericaoption exercise11,973$266,639
2026-09-14 Greenwell Scott A. · President, PharMericasell15,099$874,383
2026-07-25 ROUSSEAU JON B · See Remarks, Directorwithheld for tax56,319$4,106,218
2026-06-20 Greenwell Scott A. · President, PharMericawithheld for tax2,487$164,764
2026-06-11 Shah Nigam H. · Directoraward4,013
2026-06-05 KKR Group Partnership L.P. · 10% ownersell14,669,771$857,492,124
2026-06-05 KKR Group Partnership L.P. · 10% ownergift36,927

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

9 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy3
Buy15
Hold0
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray
16w · 26%

The most recent of 2 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
BrightSpring Health Services, Inc. Common Stock (BTSG) — The Tape